Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/28/2000 | WO2000079010A1 Compositions and methods for preventing transepithelial transmission of hiv |
12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
12/28/2000 | WO2000078970A1 Nucleic and proteinic acids corresponding to human gene abc1 |
12/28/2000 | WO2000078963A1 Serin proteinase inhibitors |
12/28/2000 | WO2000078961A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
12/28/2000 | WO2000078953A2 Human transport proteins |
12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
12/28/2000 | WO2000078949A1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
12/28/2000 | WO2000078947A1 Head trauma induced cytoplasmatic calcium binding protein |
12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
12/28/2000 | WO2000078815A1 ANTI-αvβ3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE |
12/28/2000 | WO2000078814A2 LO-CD2b ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
12/28/2000 | WO2000078813A2 Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin |
12/28/2000 | WO2000078807A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
12/28/2000 | WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules |
12/28/2000 | WO2000078805A1 Peptide having preptin functionality |
12/28/2000 | WO2000078802A2 Secreted polypeptides and corresponding polynucleotides |
12/28/2000 | WO2000078347A1 Cell growth inhibition |
12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
12/28/2000 | WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
12/28/2000 | WO2000058460A3 Casb619 involved in colon cancers |
12/28/2000 | WO2000043495A3 33 human secreted proteins |
12/28/2000 | WO2000037640A3 Compositions and methods for the treatment of tumor |
12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
12/28/2000 | CA2783140A1 Srsv detection kit |
12/28/2000 | CA2386393A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
12/28/2000 | CA2377263A1 Polynucleotides and polypeptides encoded thereby |
12/28/2000 | CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci |
12/28/2000 | CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1 |
12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
12/28/2000 | CA2375493A1 Human transport proteins |
12/28/2000 | CA2375480A1 Head trauma induced cytoplasmatic calcium binding protein |
12/28/2000 | CA2375475A1 Serin proteinase inhibitors |
12/28/2000 | CA2375414A1 Human transcriptional regulator proteins |
12/28/2000 | CA2375407A1 Rna metabolism proteins |
12/28/2000 | CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use |
12/28/2000 | CA2375207A1 Peptide having preptin functionality |
12/27/2000 | EP1063293A2 Transforming growth factor alpha H1 |
12/27/2000 | EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
12/27/2000 | EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
12/27/2000 | EP1062953A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
12/27/2000 | EP1062517A2 Diagnosis of spongiform encephalopathies using prionins |
12/27/2000 | EP1062514A2 C-myc coding region determinant-binding protein (crd-bp) |
12/27/2000 | EP1062509A2 Methods and compositions for diagnosis of rheumatoid arthritis |
12/27/2000 | EP1062364A1 Qualitative differential screening |
12/27/2000 | EP1062348A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase |
12/27/2000 | EP1062347A1 Diagnostics and vaccines for mycobacterial infections of animals and humans |
12/27/2000 | EP1062346A1 Gene encoding labyrinthin, a marker for cancer |
12/27/2000 | EP1062340A2 Compositions and methods for the treatment and prevention of metastatic disorders |
12/27/2000 | EP1062339A2 Human fgf gene and gene expression products |
12/27/2000 | EP1062338A2 Human membrane spanning proteins |
12/27/2000 | EP1062336A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
12/27/2000 | EP1062334A1 Mammalian sodium channel proteins |
12/27/2000 | EP1062332A2 Human receptor proteins; related reagents and methods |
12/27/2000 | EP1062320A1 Methods and compositions for the selective expansion of gamma/delta t-cells |
12/27/2000 | EP1062319A1 Vascular endothelial growth factor 2 |
12/27/2000 | EP1062246A1 Anti-inositolphosphoglycan monoclonal antibodies |
12/27/2000 | EP1062245A1 Products comprising inactivated yeasts or moulds and active vhh-type antibodies |
12/27/2000 | EP1062241A1 Fas-associated polypeptides |
12/27/2000 | EP1062238A1 Ecr673: a 7-transmembrane g-protein coupled receptor |
12/27/2000 | EP1062237A1 Ribonucleotide polypeptides containing metal |
12/27/2000 | EP1062236A1 31 human secreted proteins |
12/27/2000 | EP1062235A2 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
12/27/2000 | EP1062234A2 Mammalian blood loss-induced gene, kd312 |
12/27/2000 | EP1062225A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
12/27/2000 | EP1061902A1 Colonic delivery of protein or peptide compositions |
12/27/2000 | EP0804483B1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
12/27/2000 | CN1278301A Procine circoviruses, vaccines and diagnostic reagents |
12/27/2000 | CN1278300A Multivalent antigen-binding proteins |
12/27/2000 | CN1278006A Human G protein coupled receptor protein isomer, and coding series thereof |
12/27/2000 | CN1278005A Human nucleolar chromosome protein and coding series thereof |
12/27/2000 | CN1278004A Novel human immune glubulin receptor subunit protein, and coding series thereof |
12/27/2000 | CN1278003A Human spermidine/spermine acetyl transferase protein isomer, and coding series thereof |
12/27/2000 | CN1278002A Human RNA binding protein and coding series thereof |
12/27/2000 | CN1278001A Human dehydrogenase subunit protein isomer and coding series thereof |
12/27/2000 | CN1278000A Human glucotranferring protein, and coding series thereof |
12/27/2000 | CN1277999A Human cell periodic protein isomer protein, and coding series thereof |
12/27/2000 | CN1277998A Human nitrile hydrolytic enzyme protein and coding series thereof |
12/27/2000 | CN1277997A Glycoprotein relating to human muscle nutrition and coding series therefor |
12/27/2000 | CN1277996A Novel polypeptide-human galactose transferase 40, and polynucleotide for coading same |
12/27/2000 | CN1277970A Novel polypeptide-human sarcoma protein 20, and polynucleotide for coding same |
12/26/2000 | US6166290 Glutathione-S-conjugate transport in plants |
12/26/2000 | US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy |
12/26/2000 | US6166192 PGC-1, a novel brown fat PPARγ coactivator |
12/26/2000 | US6166186 Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma |
12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
12/26/2000 | US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections |
12/26/2000 | US6166180 Polypeptide for the treatment of genetic disorders associated with transmembrane protein |
12/26/2000 | US6166179 Polypeptide for the detection and treatment of cancer, inflammation, bacterial infection and autoimmune disease |
12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
12/26/2000 | US6166176 Cancer marker protein and peptides thereof |
12/26/2000 | US6166090 Prevention atherosclerosis; administering transforming growth factor |
12/26/2000 | US6165992 Histidine kinase |
12/26/2000 | US6165793 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
12/26/2000 | US6165784 Hybridoma cells which produces and secretes a monoclonal antibody which specifically binds to a conserved mammalian epitope; for the diagnosis of creutzfeldt-jacob disease |